Introduction
The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm reduction interventions.
Download as PDF
- Arabic (ar)
- Bulgarian (bg)
- Croatian (hr)
- Czech (cs)
- Danish (da)
- Dutch (nl)
- English (en)
- Estonian (et)
- Finnish (fi)
- French (fr)
- German (de)
- Greek (el)
- Hungarian (hu)
- Italian (it)
- Latvian (lv)
- Lithuanian (lt)
- Norwegian (no)
- Polish (pl)
- Portuguese (pt)
- Romanian (ro)
- Russian (ru)
- Slovakian (sk)
- Slovene (sl)
- Spanish (es)
- Swedish (sv)
- Turkish (tr)
Table of contents
- Preface
- Introductory note
- Acknowledgements
- Director's message
- COVID-19 pandemic and the drug situation
- Latest data on Europe's drug situation
- Cannabis
- Cocaine
- Amphetamine
- Metamphetamine
- MDMA
- New psychoactive substances
- LSD, DMT, mushrooms, ketamine and GHB
- Heroin and other opioids
- Production and precursors
- Drug law offences
- Injecting drug use
- Drug-related infectious diseases
- Drug-induced deaths
- Annex - National data tables